Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Agulnik

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Cancer Medicine|December 11, 2019
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcomaVictor M Villalobos, Gary Mo, Mark Agulnik, et al.
Integrative Cancer Therapies|March 24, 2004
Integrative tumor board: colon cancer with liver metastases: case presentationJennifer R Schmaltz, Mark Agulnik, Michael R Mullane, et al.
Oral Oncology|April 20, 2012
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neckCesar A Perez, Hunho Song, Luis E Raez, et al.
British Journal of Cancer|May 29, 2021
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomasBrian Schulte, Nisha Mohindra, Mohammed Milhem, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumourAndrew J Wagner, Mark Agulnik, Michael C Heinrich, et al.
Journal of Oncology Practice|January 10, 2019
Piloting a Financial Counseling Intervention for Patients With Cancer Receiving ChemotherapySheetal M Kircher, Jessica Yarber, Josh Rutsohn, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2021
An open-label single-arm phase II study of regorafenib for the treatment of angiosarcomaMark Agulnik, Brian Schulte, Steven Robinson, et al.
Head & Neck|March 25, 2009
Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinibLaura Vidal, Ming S Tsao, Gregory R Pond, et al.
Cancers|July 16, 2020
A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue SarcomasVarun Monga, Keith M Skubitz, Seth Maliske, et al.
Journal of Clinical Medicine|April 13, 2023
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to SarcomaNatalie K Heater, Scott Okuno, Steven Robinson, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Cancer Medicine|December 11, 2019
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcomaVictor M Villalobos, Gary Mo, Mark Agulnik, et al.
Integrative Cancer Therapies|March 24, 2004
Integrative tumor board: colon cancer with liver metastases: case presentationJennifer R Schmaltz, Mark Agulnik, Michael R Mullane, et al.
Oral Oncology|April 20, 2012
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neckCesar A Perez, Hunho Song, Luis E Raez, et al.
British Journal of Cancer|May 29, 2021
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomasBrian Schulte, Nisha Mohindra, Mohammed Milhem, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumourAndrew J Wagner, Mark Agulnik, Michael C Heinrich, et al.
Journal of Oncology Practice|January 10, 2019
Piloting a Financial Counseling Intervention for Patients With Cancer Receiving ChemotherapySheetal M Kircher, Jessica Yarber, Josh Rutsohn, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2021
An open-label single-arm phase II study of regorafenib for the treatment of angiosarcomaMark Agulnik, Brian Schulte, Steven Robinson, et al.
Head & Neck|March 25, 2009
Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinibLaura Vidal, Ming S Tsao, Gregory R Pond, et al.
Cancers|July 16, 2020
A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue SarcomasVarun Monga, Keith M Skubitz, Seth Maliske, et al.
Journal of Clinical Medicine|April 13, 2023
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to SarcomaNatalie K Heater, Scott Okuno, Steven Robinson, et al.
Pageof 12